Kymera Therapeutics, Inc.

KYMR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091980
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Mainolfi Nello (CEO)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+215,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

215,000.0

Filing's footnotes

1. The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.